Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Bristol-Myers Squibb
Eisai Inc.
Incyte Corporation
Thomas Jefferson University
Kymab Limited
Imperial College London
Sarcoma Oncology Research Center, LLC
BeiGene
Novartis
Amgen
Novo Nordisk A/S
Kyowa Kirin Co., Ltd.
National Cancer Institute (NCI)
Cellestia Biotech AG
Novo Nordisk A/S
Sumitomo Pharma America, Inc.
University of California, Davis
CStone Pharmaceuticals
University of Alabama at Birmingham
Celgene
Incyte Corporation
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
Big Ten Cancer Research Consortium
Can-Fite BioPharma
Alliance for Clinical Trials in Oncology
Incyte Corporation
Transgene
Gilead Sciences
Incyte Corporation
Eisai Inc.
Celgene
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
University of Texas Southwestern Medical Center
Tracon Pharmaceuticals Inc.
Abramson Cancer Center at Penn Medicine
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
Eisai Inc.
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
GlaxoSmithKline
MediGene
National Cancer Institute (NCI)
Massachusetts General Hospital
Stanford University
Otsuka Pharmaceutical Co., Ltd.
Proacta, Incorporated
Loma Linda University